Our Chief Strategy Officer Martijn Kelder will be speaking at the Cell and Gene Therapy Innovation Leadership Summit in Barcelona, next Thursday at 15:15.
His presentation will reveal Annogen’s latest developments in promoter discovery and characterization, revealing novel data on our validated T-cell specific promoters for in vivo CAR-T cell therapies now available for licensing. We will also announce our upcoming partnership with Lentitek on validating these promoters.
CGTI 2025 brings together senior leaders to address the patient-impacting challenges of intelligent manufacturing, connected processes and real-world translation in a curated in-person setting.
